Cargando…
Hyperactive PiggyBac Transposons for Sustained and Robust Liver-targeted Gene Therapy
The development of robust nonviral vectors could facilitate clinical gene therapy applications and may overcome some of the immune complications of viral vectors. Nevertheless, most nonviral gene deliver approaches typically yield only transient and/or low gene expression. To address these caveats,...
Autores principales: | Di Matteo, Mario, Samara-Kuko, Emira, Ward, Natalie J, Waddingon, Simon N, McVey, John H, Chuah, Marinee KL, VandenDriessche, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435487/ https://www.ncbi.nlm.nih.gov/pubmed/25034357 http://dx.doi.org/10.1038/mt.2014.131 |
Ejemplares similares
-
Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons
por: Tipanee, Jaitip, et al.
Publicado: (2020) -
piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts
por: Loperfido, Mariana, et al.
Publicado: (2016) -
Evolution of piggyBac Transposons in Apoidea
por: Li, Xueyuan, et al.
Publicado: (2023) -
Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy
por: Tipanee, Jaitip, et al.
Publicado: (2022) -
Genetic screens using the piggyBac transposon
por: Chew, Su Kit, et al.
Publicado: (2011)